Skip to main content
. 2021 Oct 13;12:747581. doi: 10.3389/fgene.2021.747581

FIGURE 3.

FIGURE 3

Survival analysis of CLDN10 expression in patients with gastric cancer. (A,B) Decreased expression of CLDN10 was associated with favorable prognosis of overall survival (Kaplan-Meier Plotter and GEPIA2.0), (C) progression-free survival (Kaplan-Meier Plotter) and (D) Disease-free survival (GEPIA2.0).